Indian supplement manufacturer Windlas Biotech and California-based Mateon Therapeutics and have developed an artemisinin supplement that acts as an adjunctive for COVID-19 treatment.
Content provided by Aker BioMarine | 26-Feb-2024
| White Paper
The global population is getting older—according to WHO by 2050 the world’s population over 60 years will double and the population above 80 years will...